Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cffef6a2317cd32f038e41ec3b77500 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fac0b92a110c70f74f263187060cb20 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-04 |
filingDate |
2009-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8ea4ab4e63a855c40417443bae6a2dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fb126c5ca8cbbeb769332c403a94b9e |
publicationDate |
2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010069653-A1 |
titleOfInvention |
Method for enantioselective hydrogenation of chromenes |
abstract |
A method for preparing an enantiomeric chromane, by asymmetrically hydrogenating a chromene compound in the presence of an Ir catalyst having a chiral ligand. The method includes the enantioselective preparation of enantiomeric equol. A preferred Ir catalyst has a chiral phosphineoxazoline ligand. Enantiomeric chromanes of high stereoselective purity can be obtained. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10370349-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9701655-B2 |
priorityDate |
2005-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |